Showing 1,861 - 1,880 results of 2,974 for search '"drug interaction"', query time: 0.21s Refine Results
  1. 1861

    PREVENTION OF STROKE IN ATRIAL FIBRILLATION: THE APPROACHES TO THE CHOICE OF ANTICOAGULANT, DEPENDING ON AGE by A. V. Ardashev, I. V. Zotova

    Published 2016-12-01
    “…The choice of anticoagulant should be based on a comprehensive assessment of a number of factors - the presence of significant valvular disease, kidney function, potential drug interactions, risk of complications of anticoagulant therapy. …”
    Get full text
    Article
  2. 1862
  3. 1863

    Role of the pharmacist in the management of postmenopausal breast cancer treatment with vasomotor symptoms: A case report by Megan R. Undeberg, Alanda Barash, Kimberly C. McKeirnan

    Published 2023-09-01
    “…Pharmacists can play an important role in the management of postmenopausal breast cancer and vasomotor symptoms by providing patient education and recommending medications based on treatment guidelines with consideration to side effects and drug interactions.…”
    Get full text
    Article
  4. 1864

    An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis by Luca Menestrina, Maurizio Recanatini

    Published 2022-12-01
    “…Combined therapies are then prioritized on the basis of the drugs’ separation on the human interactome and the known drug-drug interactions. We eventually collected a number of molecules, and their plausible combinations, that could be proposed for the treatment of Huntington's disease and multiple sclerosis. …”
    Get full text
    Article
  5. 1865

    Magnesium Oxide in Constipation by Hideki Mori, Jan Tack, Hidekazu Suzuki

    Published 2021-01-01
    “…Despite these advantages, emerging clinical evidence indicates that the use of magnesium oxide should take account of the most appropriate dose, the serum concentration, drug–drug interactions, and the potential for side effects, especially in the elderly and in patients with renal impairment. …”
    Get full text
    Article
  6. 1866

    DEFINITION OF ZALEPLON, ZOLPIDEM AND ZOPICLON IN BIOLOGICAL OBJECTS by V. A. Kartashov, G. P. Chepurnaya, L. V. Chernova

    Published 2019-01-01
    “…To diagnose intoxications by these medicines and other purposes (for monitoring the concentration of these medicines in the blood, studying pharmacokinetics, evaluating drug interactions, optimizing treatment control), the development of methods for defining Z-preparations in biological objects becomes important, that is currently developed insufficient. …”
    Get full text
    Article
  7. 1867

    THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY by A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev

    Published 2015-09-01
    “…New oral anticoagulants (NOAC) are promising drugs for use in oncology practice; however their use is complicated by the lack of data on efficacy and safety in these patients, potential drug interactions and the possibility of unpredictable changes in effect during chemotherapy. …”
    Get full text
    Article
  8. 1868

    Can Mesoporous Silica Speed Up Degradation of Benzodiazepines? Hints from Quantum Mechanical Investigations by Massimo Delle Piane, Marta Corno

    Published 2022-02-01
    “…The adopted computational procedure has been chosen to investigate whether silica–drug interactions favor the drug degradation mechanism or not, hindering the beneficial pharmaceutical effect. …”
    Get full text
    Article
  9. 1869

    Severe hyponatremia due to trimethoprim-sulfamethoxazole-induced SIADH by Creticus Marak, Matthew Nunley, Achuta Kumar Guddati, Prashant Kaushik, Mark Bannon, Adrita Ashraf

    Published 2022-10-01
    “…Simultaneous use of trimethoprim-sulfamethoxazole and spironolactone can cause serious drug interactions that increase the risk of hyponatremia, hyperkalemia, and overall mortality. …”
    Get full text
    Article
  10. 1870

    Augmented EHR: Enrichment of EHR with Contents from Semantic Web Sources by Alejandro Mañas-García, José Alberto Maldonado, Mar Marcos, Diego Boscá, Montserrat Robles

    Published 2021-04-01
    “…Finally, to exemplify the approach, the work includes a practical use case in which the summarized EHR is augmented with drug–drug interactions and disease-related treatment information.…”
    Get full text
    Article
  11. 1871

    Treatment of dermatophytosis in elderly, children, and pregnant women by Subuhi Kaul, Savita Yadav, Sunil Dogra

    Published 2017-01-01
    “…Terbinafine is the preferred oral agent in elderly population for treatment of extensive cutaneous disease and onychomycosis due to its lack of cardiac complications and lower propensity for drug interactions. If required, additional physical/mechanical modalities can be employed for symptomatic onychomycosis. …”
    Get full text
    Article
  12. 1872

    Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings by A. V. Kukurika, E. I. Veselova, L. E. Parolina, O. V. Lovacheva

    Published 2022-12-01
    “…In conditions of high prevalence of HIV, the pharmacovigilance of drug interactions in combination therapy is particularly relevant since HIV can indirectly increase the number of ADRs not only due to cross-toxicity but also severe immunosuppression, development of immune system recovery syndrome, opportunistic infections, a characteristic intoxication syndrome, a low index body weight and individual characteristics of patients in this category.…”
    Get full text
    Article
  13. 1873

    Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity by Silvia Cesarini, Ilaria Vicenti, Federica Poggialini, Massimiliano Secchi, Federica Giammarino, Ilenia Varasi, Camilla Lodola, Maurizio Zazzi, Elena Dreassi, Giovanni Maga, Lorenzo Botta, Raffaele Saladino

    Published 2022-12-01
    “…Unfortunately, these three drugs showed some limitations regarding potency and possible drug–drug interactions. A series of derivatives coming from a decoration approach of the privileged scaffold s-triazines were synthesized and evaluated against SAR-CoV-2. …”
    Get full text
    Article
  14. 1874

    Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified? by Nora Renz, Andrej Trampuz, Werner Zimmerli

    Published 2021-02-01
    “…The risk for emergence of rifampin resistance and multiple drug interactions are emphasized. A recent randomized controlled trial (RCT) showing no beneficial effect of rifampin in patients with acute staphylococcal periprosthetic joint infection treated with prosthesis retention is critically reviewed and data interpreted. …”
    Get full text
    Article
  15. 1875

    Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis by Han Naung Tun, May Thu Kyaw, Erik Rafflenbeul, Xiuhtlaulli López Suástegui

    Published 2022-05-01
    “…However, their use is limited by drawbacks including a narrow therapeutic range, numerous food and drug interactions, and the need for regular monitoring for dose adjustments. …”
    Get full text
    Article
  16. 1876

    Knowledge Graphs and Explainable AI in Healthcare by Enayat Rajabi, Somayeh Kafaie

    Published 2022-09-01
    “…Based on our review, knowledge graphs have been used for explainability to detect healthcare misinformation, adverse drug reactions, drug-drug interactions and to reduce the knowledge gap between healthcare experts and AI-based models. …”
    Get full text
    Article
  17. 1877

    The structure of mouse L1210 dihydrofolate reductase-drug complexes and the construction of a model of human enzyme. by Stammers, D, Champness, J, Beddell, C, Dann, J, Eliopoulos, E, Geddes, A, Ogg, D, North, A

    Published 1987
    “…These structures reveal for the first time details of drug interactions with a mammalian DHFR, which are compared with those observed from previous X-ray investigations of DHFR/inhibitor complexes. …”
    Journal article
  18. 1878

    Molecular pathways modulated by curcumin analogue, diarylpentanoids in cancer by Paulraj, Felicia Simone, Abas, Faridah, Lajis, Nordin, Othman, Iekhsan, Naidu, Rakesh

    Published 2019
    “…Future research will need to focus on drug interactions to explore potential synergistic actions of diarylpentanoids and further establish the use of diverse animal models.…”
    Get full text
    Article
  19. 1879

    Collaborative Innovation: The Future of BioPharma by Cristián Hernández-Cuevas

    Published 2007-09-01
    “…During this process, researchers develop tests to screen libraries of chemical compounds against therapeutic targets, evaluate the amount of a drug required to effectively treat the disease, study the extent to which a drug interacts only with the target, assess the presence and significance of any harmful side effects and design the way the drug is going to be administered to patients.…”
    Get full text
    Article
  20. 1880

    Common Toxic Syndromes in Psychiatric Practice by Vesile Altınyazar

    Published 2010-12-01
    “…Entoxications which are confronted frequently include clinical scenarios ranging from known drug overdose or drug interactions, as well as, illicit drug use, suicide attempt, or accidental exposure. …”
    Get full text
    Article